ClinicalTrials.Veeva

Menu

Correlation Between Access Blood Flow and Extracorporeal Blood Flow

N

National Institute of Cardiology Ignacio Chavez

Status

Unknown

Conditions

Arteriovenous Fistula

Treatments

Other: Dynamic Arterial line Pressure (DALP)

Study type

Observational

Funder types

Other

Identifiers

NCT00522704
INCich-07-08-7403

Details and patient eligibility

About

The purpose of this study is to determine if Effective Extracorporeal Blood Flow(eEBF) has correlation with Access Blood Flow (Qa), when eEBF adjusts with Dynamic Arterial Line Pressure (DALP) in patients with Arteriovenous fistulae in hemodialysis treatment.

Full description

Accesses that show a large (>15%) decrement over time in vascular access blood flow are associated with a high risk of thrombosis. Serial measurements of vascular access blood flow predict access thrombosis. At the moment, the measurement of access flow is time consuming, operator dependent, so that it cannot be done with every treatment. We hypothesized that extracorporeal blood flow at pressure of -200 to -260 mmHg in arterial line has correlation with access blood flow and this can be used to estimate access blood flow.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Chronic Kidney Disease K-DIGO 5d in hemodialysis treatment)
  • Permanent vascular accesses with native arteriovenous fistulas (AVF)
  • AVF that were at least 12 weeks old

Exclusion criteria

  • Inflammation and pain in AVF
  • Negation to participate in the study

Trial contacts and locations

1

Loading...

Central trial contact

Luis R Mariscal, M.D.; Franklin B Mora, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems